Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04019834 · ClinicalTrials.gov registry record · Early Phase 1
Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy
A Early Phase 1 study of Breast Cancer and Anesthesia, Local, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04019834 is a Early Phase 1 study of Breast Cancer and Anesthesia, Local that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 21 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04019834, a Early Phase 1 study of Breast Cancer and Anesthesia, Local, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if pre-operative regional nerve blocks compared to a placebo nerve block can decrease chronic post mastectomy pain, immediate postoperative pain and postoperative narcotic consumption.
Conditions Studied
Interventions
- DRUG regional nerve block with local anesthesia of bupivacaine with steroid
- OTHER Placebo regional nerveblock with normal saline
Study Locations (1)
Alabama
- University of Alabama at Birmingham Hospitals and Affiliated Clinics - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2021-11-25 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04019834
The ClinicalTrials.gov registry entry for NCT04019834 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which regional nerve block with local anesthesia of bupivacaine with steroid is the first listed.
NCT04019834 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04019834 about?
NCT04019834 is a clinical study titled "Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy". The purpose of this study is to see if pre-operative regional nerve blocks compared to a placebo nerve block can decrease chronic post mastectomy pain, immediate postoperative pain and postoperative narcotic consumption.
What is the current status of trial NCT04019834?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2020-07-06. Estimated completion is 2021-11-25.
What conditions does trial NCT04019834 study?
This clinical trial studies the following conditions: Breast Cancer, Anesthesia, Local, Mastectomy, Narcotic Use.
What interventions are being tested in trial NCT04019834?
The interventions under investigation include: regional nerve block with local anesthesia of bupivacaine with steroid (DRUG), Placebo regional nerveblock with normal saline (OTHER).
Who is sponsoring clinical trial NCT04019834?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04019834 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
RECRUITING · Early Phase 1
-
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
RECRUITING · Early Phase 1
-
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
RECRUITING · Early Phase 1
-
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
RECRUITING · Early Phase 1
-
FES BPET-DBT in Newly Diagnosed Breast Cancer
RECRUITING · Early Phase 1
-
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.